May 15 (UPI) --Treatment with the hepatitis drug interferon-alpha-2b might speed recovery for people with COVID-19, a small study published Friday by the journal Frontiers in Immunology found.

The infant's mother was initially evaluated in St. Louis Children's Hospital at 10 years of age with acute onset chorea, splenomegaly and thrombocytosis (platelet count of 1.5 million/cumm). Her ...

The COMBI study, a prospective, open‐label, single‐arm phase 2 study ongoing in Denmark, is investigating the feasibility of treating patients with low- to intermediate-risk myelofibrosis ...

Interferon alfa-2b (IFN alpha-2b) exhibits antitumor activity in metastatic melanoma and on this basis has been evaluated as an adjuvant therapy following surgery for deep primary (T4) or regionally ...

IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. Roferon-A is an injectible, ...

Adverse event profile of regimen containing BMS-790052 was consistent with that of treatment with PEG-Interferon alfa and ribavirin alone “There currently exists a medical need for new medicines or ...

Please provide your email address to receive an email when new articles are posted on . The addition of interferon alfa to temozolomide significantly extended survival among patients with newly ...

IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. Intron A is an injectible recombinant ...

Twenty-four patients with human papillomavirus (HPV)-associated cervical intraepithelial neoplasia (CIN); of whom 13 had CIN 1, 8 had CIN 2, and 3 had CIN 3; were treated with recombinant alpha 2b ...

In a recent study posted to bioRxiv *, researchers performed an analysis of molecular variance (AMOVA) in 59 haplotypes of the interferon (IFN)-alpha (α) /beta (β) receptor (IFNAR) gene, departing ...